Stock BERLDRG6 BERYL DRUGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Beryl Drugs Limited

Equities

BERLDRG6

INE415H01017

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 03:30:56 03/07/2024 pm IST 		5-day change 1st Jan Change
32.27 INR +0.53% Intraday chart for Beryl Drugs Limited -3.56% +45.95%
30/05 Beryl Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
12/02 Beryl Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 60.86 42.4 18.51 33.52 53 61.67
Enterprise Value (EV) 1 72.58 73 65.03 78.22 99.22 101.4
P/E ratio 6.13 x 7.21 x 40.6 x 14.1 x -8.04 x 8.05 x
Yield - - - - - -
Capitalization / Revenue 0.4 x 0.33 x 0.14 x 0.24 x 0.36 x 0.23 x
EV / Revenue 0.48 x 0.56 x 0.51 x 0.56 x 0.68 x 0.38 x
EV / EBITDA 6.06 x 6.08 x 5.82 x 4.84 x 17.1 x 4.6 x
EV / FCF -7.86 x -2.46 x -2.4 x -4.75 x -17.5 x -25.9 x
FCF Yield -12.7% -40.6% -41.7% -21.1% -5.72% -3.86%
Price to Book 0.91 x 0.56 x 0.24 x 0.42 x 0.73 x 0.76 x
Nbr of stocks (in thousands) 5,072 5,072 5,072 5,072 5,072 5,072
Reference price 2 12.00 8.360 3.650 6.610 10.45 12.16
Announcement Date 07/09/18 04/09/19 30/11/20 03/09/21 03/09/22 28/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 152.5 129.6 128.2 140.9 146 268.9
EBITDA 1 11.98 12.01 11.17 16.15 5.808 22.04
EBIT 1 8.686 8.803 4.604 3.447 -5.04 13.9
Operating Margin 5.7% 6.79% 3.59% 2.45% -3.45% 5.17%
Earnings before Tax (EBT) 1 12.73 7.963 1.579 3.48 -9.503 9.838
Net income 1 9.929 5.907 0.4794 2.396 -6.59 7.66
Net margin 6.51% 4.56% 0.37% 1.7% -4.51% 2.85%
EPS 2 1.958 1.160 0.0900 0.4700 -1.300 1.510
Free Cash Flow 1 -9.23 -29.63 -27.11 -16.47 -5.677 -3.912
FCF margin -6.05% -22.86% -21.15% -11.69% -3.89% -1.46%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 07/09/18 04/09/19 30/11/20 03/09/21 03/09/22 28/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net Debt 1 11.7 30.6 46.5 44.7 46.2 39.7
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.9779 x 2.548 x 4.165 x 2.767 x 7.958 x 1.801 x
Free Cash Flow 1 -9.23 -29.6 -27.1 -16.5 -5.68 -3.91
ROE (net income / shareholders' equity) 15.8% 8.32% 0.63% 3.08% -8.66% 9.97%
ROA (Net income/ Total Assets) 5.1% 4.33% 1.83% 1.21% -1.73% 4.92%
Assets 1 194.5 136.4 26.23 197.8 381.5 155.8
Book Value Per Share 2 13.10 14.80 15.00 15.60 14.40 15.90
Cash Flow per Share 2 0.2800 0.2000 0.7800 0.8900 0.5400 0.5600
Capex 1 10 62.5 18.8 16.7 4.16 15.6
Capex / Sales 6.56% 48.25% 14.63% 11.86% 2.85% 5.81%
Announcement Date 07/09/18 04/09/19 30/11/20 03/09/21 03/09/22 28/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
BERYL DRUGS LIMITED Stock Beryl Drugs Limited
+45.95% 1.95M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+54.07% 816B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+38.59% 634B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.05% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.44% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.72% 293B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.40% 238B
ROCHE HOLDING AG Stock Roche Holding AG
+0.61% 222B
NOVARTIS AG Stock Novartis AG
+13.24% 218B
AMGEN INC. Stock Amgen Inc.
+7.42% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BERLDRG6 Stock
  4. Financials Beryl Drugs Limited